Nefiracetam

DB13082InvestigationalSmall molecule

Nefiracetam has been used in trials studying the treatment of Alzheimer's Disease.

Mechanism: Pharmacologically active on Metabotropic glutamate receptor 5, Protein kinase C, and NMDA receptor
Curator reviewed
Formula / weight: C₁₄H₁₈N₂O₂ · 246.31 g/mol (avg)
Code names: DM 9384

Resolves to

Compound

Structure

InChIKeyNGHTXZCKLWZPGK-UHFFFAOYSA-NSMILESCC1=CC=CC(C)=C1NC(=O)CN1CCCC1=O

Targets

What you can answer from here — as of July 07, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

666Drug interactionsStructured to mechanism, not free text

1Clinical trialPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Nefiracetam, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.